N-(2-Methoxy-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-3-yl)methanesulfonamide, 95.0%, 250mg

4-Hydroxy-5-methylpyrimidine, 95.0%, 5g

Flavoxate Hydrochloride>98.0%(HPLC)(T)25g

1-(4-Bromo-3-fluorophenyl)cyclopropanecarboxylic acid, 95.0%, 5g

2-(2,5-Dibromophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 5g

3-Butoxyphenylboronic acid, 95.0%, 1g

N4-(Benzo[d][1,3]dioxol-5-ylmethyl)-6-(3-methoxyphenyl)pyrimidine-2,4-diamine, 95.0%, 10mg

n-(2-Aminoethyl)-3-({2-[(2-aminoethyl)carbamoyl]ethyl}({2-[bis({2-[(2-aminoethyl)carbamoyl]ethyl})amino]ethyl})amino)propanamide, 98%, 1g

4'-Acetoxyacetanilide>99.0%(HPLC)(N)5g

Methyl 2-(trifluoromethyl)benzoate, 97.0%, 10g

1-(3-Cyanobenzyl)imidazole, 97.0%, 1g

4,4,5,5-Tetramethyl-2-(2-methylprop-1-en-1-yl)-1,3,2-dioxaborolane, 95.0%, 500g

(Z)-(3)-Iodoacrylic acid, 95.0%, 5g